We are thrilled to announce that the U.S. FDA has cleared our IND application and granted Fast Track designation for our investigational combination therapy, tobevibart and elebsiran, for the treatment of chronic #hepatitis delta infection. Learn more here: https://bit.ly/4eFyNx5 #hepatitisdelta #hepatitisD #hepD
Great success and awesome Tarik Asselah, great friend, that presented breakthrough data at EASL 2024 in Milan 20 days ago...💪💪💯💯✌✌
Congratulations Vir Biotechnology, Inc.. Great news for people living with hepatitis delta.
Congrats Vir Biotechnology, Inc.
Gilead Sciences, look behind you 😁
Congratulations
Congratulations
Congratulations
excellent news
Congratulations!
Chief Scientific Officer at Intellia Therapeutics, Inc.
1moSo glad to see this moving forward as envisioned as originally designed! ALN-HBV01 and 02!